Hemostatic adhesive bandage

• US 4,616,644 A
• Filed: 06/14/1985
• Issued: 10/14/1986
• Est. Priority Date: 06/14/1985
• Status: Expired due to Term

• Current Assignee: Johnson & Johnson Medical Incorporated (Johnson & Johnson)
• Original Assignee: Johnson & Johnson Services Incorporated (Johnson & Johnson)
• Inventors: Wolf, Stephen J., Saferstein, Lowell, Lindquist, Julius A.
• Primary Examiner(s): McNeill, Gregory E.
• Application Number:
  US06/744,829
• Time in Patent Office: 487 Days
• Field of Search: 128/156, 128/155, 128/268
• US Class Current: 602/48
• CPC Class Codes: A61F 13/0203 with fluid retention members
• CPC Class Codes: A61F 2013/00472 with chemical means
• CPC Class Codes: A61L 15/26 Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/225 takes precedence
• CPC Class Codes: A61L 15/58 Adhesives
• CPC Class Codes: A61L 2400/04 Materials for stopping bleeding
• CPC Class Codes: C08L 71/02 Polyalkylene oxides

Abstract

Hemostatic adhesive bandages are disclosed wherein a very thin coating of a high molecular weight polyethylene oxide is applied to the surface of the perforated plastic film wound release cover of an adhesive bandage, in a manner compatible with commonly used high speed production techniques and equipment, which stop the bleeding faster when applied to minor cuts.

Claims

1. In an adhesive bandage of the type used on minor cuts and wounds, which consists of a pressure-sensitive adhesive coated backing having attached thereto an absorbent pad bandage portion covered with a perforated plastic film wound release cover, the improvement comprising:

a very thin coating comprising a polyethylene oxide having a molecular weight of at least 600,000, on said wound release cover, thereby to improve the hemostatic effect of said adhesive bandage.

2. The adhesive bandage of claim 1, wherein the polyethylene oxide has a molecular weight of at least 4,000,000.

3. The adhesive bandage of claim 2, wherein the add-on weight of the polyethylene oxide is from 1%-10% of the weight of the perforated plastic film wound release cover to which it is added.

4. The adhesive bandage of claim 3, wherein the add-on weight of the polyethylene oxide is from 2%-8% of the weight of the perforated plastic film wound release cover.

5. The adhesive bandage of claim 3, wherein the wound release cover is made from polyethylene, polypropylene or polyester perforated plastic film.

6. The adhesive bandage of any of claims 1-5 in sterile form.

7. A hemostatic adhesive bandage comprising a backing material, a pressure-sensitive adhesive coating on one side of said backing material, an absorbent pad secured to said side of said backing material, a perforated film wound release cover overlying said absorbent pad, and on the outer surface of said wound release cover a very thin coating comprising polyethylene oxide having molecular weight of at least 600,000.

8. A process for improving the hemostasis effect of an adhesive bandage of the type used on minor cuts and wounds which consists of a pressure-sensitive adhesive coated backing covered with a perforated plastic film wound release cover comprising carrying out all steps otherwise used to manufacture said adhesive bandage, but additionally dissolving apolyethylene oxide having a molecular weight of at least 600,000 in a solvent, coating the resultant solution on the wound release cover, evaporating off the solvent leaving a very thin coating of polyethylene oxide on the wound release cover.

9. A process of claim 8, wherein the concentration of polyethylene oxide dissolved in the solvent is from 0.5 to 65%.

10. The process of claim 9, wherein said concentration is from 1.0 to 3.0%.